Welcome to our dedicated page for Hercules Capital news (Ticker: HTGC), a resource for investors and traders seeking the latest updates and insights on Hercules Capital stock.
Hercules Capital Inc. (NYSE: HTGC) maintains this dedicated news hub for investors tracking its specialty financing activities in technology, life sciences, and renewable energy sectors. Access timely updates on the company’s venture debt solutions, including senior secured loans and strategic partnerships with venture-backed enterprises.
This resource consolidates all official press releases and market-relevant developments, from quarterly earnings to executive leadership updates. Users will find detailed information on financing agreements, portfolio company milestones, and regulatory filings – essential for understanding HTGC’s role in venture growth capital markets.
Key content includes updates on biotechnology sector lending, renewable energy project financing, and structured debt arrangements with emerging technology firms. The curated news flow helps stakeholders monitor how Hercules Capital supports high-growth companies through customized financing solutions.
Bookmark this page for direct access to primary source materials about HTGC’s market activities. Check regularly for insights into how the company navigates opportunities in venture debt financing while maintaining its position as a leading provider of non-dilutive growth capital.
IVERIC bio, Inc. (Nasdaq: ISEE) has secured a $250 million term loan debt financing facility from Hercules Capital (NYSE: HTGC) and Silicon Valley Bank. This non-dilutive financing strengthens the company's balance sheet, allowing it to fund the potential launch of Zimura® (avacincaptad pegol) in the U.S., pending regulatory approval. The initial $50 million will be drawn in July 2022, with additional funds contingent on achieving performance milestones. Iveric plans to report data from the GATHER2 clinical trial in September 2022, crucial for Zimura's development.
Hercules Capital, Inc. (NYSE: HTGC) announced a supplemental cash distribution of
Hercules Capital, the leading specialty finance provider, announced a second quarter 2022 cash distribution of $0.35 per share. The record date is August 9, 2022, with payments made on August 16, 2022. The company's distribution policy aims to allocate approximately 90% to 100% of its taxable income. For the second quarter, 87.1% of the declared distributions were from current and accumulated earnings. Hercules has committed over $14 billion to more than 570 companies since its inception in December 2003.
Hercules Capital, Inc. (NYSE: HTGC) has announced a conference call scheduled for July 28, 2022, at 2:00 p.m. PT to discuss its second quarter 2022 financial results. The results will be released after market close the same day. Hercules Capital, a leader in providing senior secured loans to venture-backed companies, has committed over $14 billion to more than 570 companies since its inception in 2003. Investors can participate through a live webcast or via telephone registration.
Geron Corporation announces an expansion of its loan facility with Hercules Capital and Silicon Valley Bank, increasing access from $75 million to $125 million. This amendment allows for an additional $50 million in potential non-dilutive capital in 2023, crucial for the company as it anticipates top-line results from the Phase 3 IMerge trial in January 2023. Funding aims to support operations and potential commercialization of imetelstat until mid-2024.
Hercules Capital (NYSE: HTGC) announced the appointment of DeAnne Aguirre as an independent board member, effective June 23, 2022. With over 30 years of executive experience in managing complex business units, Aguirre will join the Nominating and Corporate Governance Committee. CEO Scott Bluestein highlighted her extensive industry experience as a valuable asset for the firm, especially as it expands its market reach. Aguirre's previous roles include being Managing Partner at PricewaterhouseCoopers and serving on the board of Cisive.
Hercules Capital has successfully closed two new debt financings, raising a total of $200 million. This includes $150 million in Class A Notes, which have a 4.95% fixed interest rate and mature on
Hercules Capital (NYSE: HTGC) has successfully increased its credit facilities, raising its MUFG facility from
The total combined credit capacity now stands at
Hercules Capital, Inc. (NYSE: HTGC) announced a BBB- investment grade credit rating from Fitch Ratings with a stable outlook. This rating acknowledges Hercules' diversified lending model and strong credit track record. Key highlights include a focus on first lien debt investments, a solid asset coverage ratio above 25%, and a flexible funding strategy. Since December 2003, Hercules has committed over
Hercules Capital, Inc. (NYSE: HTGC) will conduct its 2022 Annual Meeting of Stockholders virtually on June 23, 2022, at 9:00 a.m. Pacific Time. The proxy statement was sent on May 4, 2022, to shareholders of record as of April 25, 2022. Key voting matters include the election of two directors, an advisory vote on executive compensation, and the ratification of the independent accounting firm. Hercules Capital provides senior secured venture growth loans and has committed over $14 billion to over 570 companies since its inception in December 2003.